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Abstract 
A study of a variety of two treatment p period crossover designs was 
reported earlier by the authors. In the present paper, three and four treat-
ment p period crossover designs are studied. A number of designs have been 
described in published literature, but no comparison of their efficiency has 
been made. This is done herein using a criterion of efficiency involving 
the v-1 linearly independent contrasts among the v treatment effects. The 
crossover designs are of two basic types, i.e., when treatments do and do 
not precede themselves in a sequence. The designs are compared using direct 
effects, first order residual effects, and cumulative effects. For three 
treatments 3, 6, and 9sequencesand 3,4,···,15 periods were considered. For 
four treatments 4, 8, 12, and 16 sequences and 4,5,··· ,20 periods were studied. 
No one design was found to have uniformly best efficiency over all periods and 
sequences. Although patterns of efficiency of three and four treatment designs 
were generally the same, there were differences. This means that the efficiency 
of designs is not invariant with respect to number of periods, number of se-
quences, number of treatments, and type of design. 
In addition to comparing efficiencies of various designs for direct, re-
sidual, and cumulative effects, the three treatment designs were studied to 
determine estimability of direct effect by first order residual effect inter-
action and cumulative effect by period interaction. There was only one of the 
designs which allowed estimation of the (v-1)2 = 4 linearly independent contrasts 
among the v2 = 9 direct by first order residual effect interaction terms. Three 
of the designs provided estimators of contrasts for the cumulative treatment 
effect by period interaction. 
THREE AND FOUR TREATMENT CROSSOVER DESIGNS 
FOR ESTIMATING VARIOUS EFFECTS 
l. Introduction 
A variety of published designs provide efficient estimators of contrasts 
among direct and among residual treatment effects when the number of treatments 
exceeds two (see Kershner (1980) for a list of reference~). We consider the 
variance optimality and some estimability properties of the designs of Cochran 
et al. (1941), Williams (1949), Quenouille (1953), Lucas (1957), Linnerud, Gates 
and Danker (1962), Federer and Atkinson (1964), and Atkinson (1966) (see Table 1). 
Cochran et al. (1941) and Williams (1949) made use of orthogonal latin squares. 
The sequences were formed by placing the orthogonal latin squares side by side. 
Also, for v even it is possible to use a single square of v sequences and v periods 
which is balanced for one-period residual effects. The designs of Quenouille (1953) 
are of the following form for v = 3: 
A B c A A B B c c 
A B c B c A c A B 
B c A B c A c A B 
B c A c B c A B A 
c A B c B c A B A 
c A B A A B B c c 
The designs of Lucas (1957) used a single latin square and then added another row 
duplicating the last row of the latin square. Linnerud et al. (1962) repeated the 
last row k times. The Federer and Atkinson (1964) designs used vt+l periods and 
used the results from all periods or for omitting the first period; they used 
the CAC-W designs but added the extra v(t-1) + l periods. An example of their 
designs for v = 3, for 3 and 6 sequences, and 7 periods is: 
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Table l 
A Listing of Some Three and Four Treatment Crossover Designs 
Class and Design 
CO(v,hv,v) 
CO(v,hv,v+i), 
h=2,···,v-l, v odd 
h=l,···,v-1, v even 
i=l or 2 
CO(v,vj,vq+l), j=l,··· ,v-l 
q=l,2,3 
co(v,hv,kv), k=2,3,··· 
CO(v,~,2v) 
Abbreviated 
Notation 
CAC-W 
L-L 
FA 
A(k) 
QBP 
Literature Reference 
Cochran, Autrey, Cannon (1941) 
Williams (1949) 
Lucas (1957) 
Linnerud, et al. (1962) 
Federer (1955) 
Federer and Atkinson (1964) 
Atkinson (1966) 
Quenouille (1953) 
Berenblut (1964) 
Patterson (1973) 
(See Kershner, 1980, and Kershner and Federer, 1981, for definitions and notations.) 
A B C 
B C A 
C A B 
A B C 
C A B 
B C A 
A B C 
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A B 
B C 
C A 
A B 
C A 
B C 
A B 
C A B C 
A C A B 
B B C A 
C A B C 
B B C A 
A C A B 
C A B C 
The Atkinson (1966) designs were develo~ed to reduce the variance of residual 
effects over the ~revious designs, leaving the variance of the direct effects 
in the FA and A(2) designs the same. An exam~le of the latter design for v = 3, 
k = 2, s = 3,6, and ~ = 7 is: 
A B C 
A B C 
B C A 
B C A 
C A B 
C A B 
A B C 
A B C 
A B C 
B C A 
B C A 
C A B 
C A B 
A B C 
A B C 
A B C 
C A B 
C A B 
B C A 
B C A 
A B C 
With the exception of Cochran et al. (1941) and Williams (1949) designs, all 
the designs have the ~roperty that individual sampling units receive at least one 
of the treatments more than once. The designs of Quenouille (1953), Lucas (1957), 
Linnerud, et al. (1962) and Atkinson (1966) share the ~roperty that treatments 
precede themselves. Variance optimality of these designs for a varying number of 
periods is an unsolved ~roblem in that criteria for variance optimality are for 
one set of effects, not several as encountered in crossover designs. It is 
addressed here for three and four treatment crossover designs. One comparison 
of the variance o~timality of several classes of designs is given in Berenblut 
and Webb (1974), but these authors do not consider varying the number of periods, 
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sequences and amount of re~lication as is done here. An additional ~roblem of 
ascertaining the estimability of contrasts among certain interaction effects is 
also considered. 
For two treatments A and B, the criteria used for choosing efficient designs 
is based on minimizing the variance of differences of direct effects, var(~A-~B)' 
or the variance of differences of one ~eriod residual effects, var(pA-pB). Such 
~rocedures are easily justified on the groundsthat it is com~arisons among the 
various treatment effects which are of ~rimary interest. When the number of 
treatments is v ~ 3, there will be v-l linearly inde~endent (LIN) contrasts among 
the direct and among the residual treatment effects which need to be considered 
in com~arisons of variance o~timality. The measure of variance o~timality ado~ted 
here is the determinant of the variance-covariance matrix of a set of v-l LIN 
estimators of contrasts among the direct, among the residual effects, and among 
the cumulative treatment effects. 
2. A General Formulation 
Any linear model based on (3.1) of Kershner and Federer (1981) can be cast 
in matrix form as 
y=Xb+e (2.1) 
where l = [y .. k} is the lexicon-ordered ns~ X l vector of observations, ~ is a 
J.J 
design matrix consisting of O's and l's of order ns~ X q, b is the q X l vector 
of ~o~ulation ~arameters, and the covariance structure is such that 
var(e) = V = OL*I ;:...-p -ns 
where * denotes a right Kronecker ~roduct. 
(2.2) 
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Note that yin (2.2) will be positive definite when -l/(p-1) < p < l. 
A set of generalized Aitken estimators of b in (2.1) is given by 
(2. 3) 
where (~'y-~)- is a symmetric reflexive generalized inverse of ~·y-l~ satisfying 
(i) ~·y-l~c~·y-~)-~·y-1~ = ~·y-1~ , 
(ii) c~·y-1~)-~·y-l~c~·y-~)- = c~·y-~)- , 
(iii) [(~·y-~)-]' = (~·y-1~)-
The covariance matrix of b0 in (2.3) is then 
(2.4) 
One set of v-l LIN contrasts among, say, the direct effects can be of the 
form 
K'b = 
- 'L v 
- 'L 
v (2.5) 
Equivalently, one could consider a set of v-1 LIN contrasts among the residual 
effects such as 
L'b = (2.6) 
Pv-l - Pv 
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In (2.5) ~' is a v-1 X q matrix of contrast coefficients having full row rank 
v-1. The BLUE of (2.5) is: 
(2.7) 
which has a variance-covariance matrix of order v-1 given by 
(2.8) 
Berenblut and Webb (1974) use the criteria of D-optimality (e.g., Kiefer 
(1959)) to compare the variance optimality of certain designs. This procedure 
rariks designs on their ability to maximize ~~~~-l~l or equivalently to minimize 
IC~,~-l~)-1 1. Although this procedure demands that~ in (2.1) be of full column 
rank, Berenblut and Webb note that ranking designs on the basis of this criteria 
is independent of the manner in which the model in (2.1) is reparameterized to 
yield a design matrix of full column rank. 
The criteria of D-optimality is not used here. Instead the designs are 
compared on the basis of their ability to minimize the generalized variance in 
(2.8). By analogy with the two treatment case, this procedure is more intuitively 
appealing than D-optimality since often it is only the v-1 LIN contrasts among 
the various treatment effects which are of primary interest. 
For use as a criterion of variance optimality three features of (2.8) are 
noted: 
(i) X can have less than full column rank, 
(ii) ~'(~'~-~)-~is nonsingular, and 
(iii) ranking the designs on the basis of (2.8) is independent of the choice 
of the particular form of the v-1 LIN contrasts generated by K' in (2.5). 
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The development of these three features is given in Kershner (1980). 
3. Variance Optimality with Respect to Contrasts 
Among Treatment Effects 
Using the notation in the above section, several classes of crossover designs 
for three treatments are now compared on the basis of the variance optimality of 
estimators of contrasts among direct, first-order residual, and cumulative 
treatment effect, i.e., 
min D = min l~'var(~0 )~1 = lvar I , 
min R =min l~'var(~0 )~1 = lvar [ Pl - Pv] I 
Pv-l - Pv ' 
and 
min C = min I (K+L) 'var(b0)(K+L) I = lvar 
= lvar 
respectively. 
Tv-l + Pv-l - Tv - Pv 
- T v 
I , 
(3.1) 
( 3. 2) 
I , 
(3.3) 
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For each of the designs listed in Table 1 the number of periods is varied 
from v to 5v and the number of sequences is taken to be 3, 6 or 9 for L-L, FA 
and A(k) while QBP is only defined for 9 sequences. Note that when s = 6 and 
p = 3, CAC-W, L-L, and FA are identical residual balanced orthogonal.latin squares. 
The FA design is constructed according to Federer and Atkinson (1964). The A(k) 
designs are derived from the FA designs by repeating each row k times. The QBP 
design as originally constructed in Quenouille (1953) and Berenblut (1964) 
defined a CO(v,v2,2v). But here additional periods are added to define a CO(v,v2,5v). 
The design is replicated over the periods in such a way that periods 1,···,2v 
define a QBP design as do periods 2v+l,···4v; 4v+l,··· ,6v, etc. For L-L, FA and 
A(k), a nine sequence design is constructed by repeating one of the squares in 
the orthogonal set. In particular, the square defined by s = 1 in Federer and 
Atkinson (1964) is replicated. Tables 2, 3 and 4 show the values of (3.1), (3.2) 
and (3.3), respectively, for these designs. The values of the determinants in 
these tables are unique to within a multiple of ISI 2 [cr2 (l-p)]2 where Q is an 
arbitrary nonsingular matrix of order 2 as considered in QK'b = C'b. Note that 
since cr2 (1-p) is a common factor, the relative ranking of the designs is invariant 
with respect to p. For all computations, a single observation in (2.1) is defined 
to have the expected value: 
~ + n. + ~. + Tt + p , 
1 J r (3.4) 
where~ is a general mean effect, n. is the effect of period i, i=l,2,···,p, 
1 
~j is the effect of the jth sequence, j=l,2,··· ,s, Tt is the direct effect of 
treatment tin the period in which it is applied, t=l,2,··· ,v, and p is the carry-
r 
over or residual effect of treatment r in the first period after it was applied, 
r=l,2,···,v. 
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On referring to Table 2, note that when the number of treatment sequences 
is three, A(2) minimizes the expression for D in (3.1) when p = 3 or 5 or p ~ 9. 
The FA design minimizes D when the number of treatment periods is 8, and, when 
the number of periods is four, L-L minimizes D. Note that when p = 6 or 7, the 
FA and A(2) designs provide equally efficient estimators of contrasts among direct 
effects. 
The L-L and FA designs minimize D when s = 6 or 9 and p = 3 while for s = 6 
or 9 and p = 4, L-L minimizes D. For s = 6 and p ~ 5, A(2) minimizes D and, for 
s = 9 and p ~ 5, QBP minimizes D. 
The FA design tends to equalize the relative amount of within s.u. replica-
tion of direct and residual effects as the number of periods is increased. How-
ever, this property does not tend to make this design as efficient as the L-L 
design for p = 4 or 5 or the A(2) design when p ~ 6. The L-L and A(2) designs 
will generally be more efficient than FA since they have treatments preceding 
themselves in the sequences in addition to a varying degree of balance among 
direct and residual effects for a given number of treatment periods. 
The A(3) design is inefficient for estimating contrasts among direct effects. 
When p = 3, contrasts among direct effects are not estimable for A(3) since they 
are completely confounded with contrasts among the sequence effects in (3.4). 
Design A(3) is a CR(3,3,3) when p = 3. Under a no-sequence-effects model and 
when pis sufficiently small (i.e., close to -i), A(3) will minimize D. 
The values of R given in expression (3.2) are shown in Table 3. When s = 3 
and p ~ 8, A(2) minimizes R. The A(3) design minimizes R when s = 3 and p = 3, 
and, for p = 4 and 5, L-L minimizes R. Note that when s = 3 and p = 6 or 7, the 
FA and A(2) designs are equally efficient. For the six or nine sequence designs, 
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Table 2 
Values of Generalized Variance for a LIN Set 
of Two Estimatable Contrasts Among Direct Effects 
Type of Number of Treatment Periods 
s Design 3 4 5 6 7 e 9 10 ll 12 13 14 15 
X 10-2~ x lo-3a2 
3 L-L 833 4o 27 - - - - - - - - - -
FA 833 53 42 14 10 85 69 63 47 36 30 27 24 
A(2) 133 42 21 14 10 90 49 43 28 26 20 19 15 
A(3) - 75 33 31 13 ll 10 J 63 6o 57 33 31 30 
x lo-3a2 
6 L-L 130 53 44 - - - - - - - - - -
FA 130 83 57 34 26 21 15 13 ll 9 8 7 6 
A(2) 284 99 34 28 18 16 ll 10 7 6 5 5 4 
A(3) - 176 81 74 25 23 22 13 12 12 8 7 7 
x lo-3a2 X lo-4a2 
9 L-L 69 25 21 - - - - - - - - - -
FA 69 44 27 15 12 92 69 58 48 39 34 30 25 
A(2) 13 44 16 13~ 75 49 44 31 28 22 21 17 
A(3) - 79 36 33 12 10 10 1 58 56 55 34 33 32 
Q,BP 77 28 14192 71 56 43 35 28 23 20 17 15 
- ll -
Table 1 
Values of Generalized Variance for a LIN Set 
of Two Estimable Contrasts Among Residual Effects 
Ty:pe of Number of Treatment Periods 
s Design 3 4 5 6 7 l::l 9 10 ll 12 13 14 15 
x lo-2cr2 X l0-3cr2 
3 L-L 2700 62 33 - - - - - - - - - -
FA 2700 83 64 22 14 ll 90 76 57 43 35 31 27 
A(2) 1200 75 48 22 14 ll 65 52 36 31 24 21 18 
A(3) 675 675 64 42 24 16 131 76 69 64 4o 34 33 
xlo-2cr2 x lo-3cr2 
6 L-L 42 83 54 - - - - - - - - - -
..__ 
FA 42 13 90 52 34 27 20 16 13 ll 9 8 7 
A(2) 256 18 77 43 23 20 14 12 9 8 6 5 4 
A(3) 169 159 15 10 147 34 29 16 14 14 9 9 8 
x lo-3cr2 x lo-4cr2 
9 L-L 223 39 25 - - - - - - - - - -
FA 223 69 43 23 15 12 90 70 59 47 39 34 29 
A(2) 1156 79 36 20 ll f90 64 53 4o 34 26 24 20 
A(3) 750 71 69 46 21 15 13 J 70 65 61 42 38 36 
@P 235 56 26 14193 71 55 43 35 28 23 20 17 
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FA and L-L minimize R when p = 3 and, for s = 6 or 9 and p = 4 or 5, L-L minimizes 
R. When s = 6 and p ~ 6, A(2) minimizes R while for s = 9 and p ~ 6, QBP mini~ 
mizes R. 
Designs having the property that treatments precede themselves tend to be 
efficient for estimating contrasts among cumulative treatment effects (see Table 
4). The A(3) design in particular is optimal with respect to minimizing C in 
(3.3) for p ~ 8 and for s = 3, 6 or 9. When s = 3, A(3) is uniformly optimal. 
The A(2) design is optimal when s = 3 and p = 3, 4 or 6. When s = 3 and p = 5, 
A(3) is optimal. When s = 6 or 9 and p = 6 or 7, A(2) is optimal for estimating 
contrasts among cumulative treatment effects. For s = 6 and p = 3, FA and L-L 
minimize C in (3.3) while for s = 9 and p = 3 QBP minimizes C. When s = 6 or 
9 and p = 4 or 5 L-L minimizes C. 
Many times in experimental work the total sample size rather than the actual 
number of sequences might be fixed, e.g., by cost considerations. When this is 
the case, one may want to compare the variance optimality of various designs for 
a fixed number of sampling units (s.u. 's). In this case, several s.u. 's are 
randomly assigned to each of the sequences in the design. For example, if l8k 
s.u. 's are available, where k = 1,2,3,···, one might want to compare 3k repli-
cations of the six sequence designs such as FA, L-L or A(k) with 2k replications 
of the nine sequence QBP design for a varying number of periods. This is done 
in Table 5. The results tend to reinforce the optimality properties noted pre-
viously. When p = 3, FA and L-L are variance optimal for estimating contrasts 
among direct, residual and cumulative treatment effects. When p = 4, L-L is 
variance optimal with respect to estimating contrasts among direct effects, and 
it is optimal for residual effects when p = 4 or 5. The QBP design is optimal 
for residual effects when p ~ 6. The A(3) design is the optimal design for esti-
mating contrasts among cumulative treatment effects when p ~ 4. 
s 
3 
6 
9 
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Table 4 
Values of Generalized Variance for a LIN Set of Two Estimable 
Contrasts Among Cumulative Treatment Effects 
Type of Number of Treatment Periods 
Design 3 4 5 6 7 8 9 10 ll 12 13 
Xl0-1a2 x lo-2a2 
L-L 133 20 87 - - - - - - - -
FA 133 56 l 47 16 10 86 69 61 46 34 29 
A(2) 4o 12 96 29 28 18 14 9 8 5 5 
A(3) - 19 I 71 31 27 12 8 8 6 5 4 
14 
-
26 
4 
4 
x lo-2a2 x 1o-3a2 
L-L 203 27 14 - - - - - - - - -
FA 203 88 64 36 26 21 15 12 10 85 72 63 
A(2) 859 28 15 56 48 34 32 22 19 14 13 10 
A(3) - 441 171 74 53 26 17 16 12 10 10 8 
x lo-2a2 x 1o-3~ 
L-L 110 73 66 - - - - - - - - -
FA 110 47 30 16 12 93 69 56 47 38 32 28 
A(2) 388 12 72 26 22 16 14 10 9 6 6 5 
A(3) - 197 77 33 24 12 8 7 6 5 5 4 
QBP 94 21 87 46 33 26 20 16 13 10 9 8 
15 
-
22 
4 
3 
-
54 
10 
7 
-
24 
4 
3 
7 
Type 
Direct 
Residual 
Cumulative 
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Values of Generalized Variance for Contrasts Among Direct, 
Residual, and Cumulative Effects for Fixed Sample Size 
Number of Treatment Periods 
s Design 3 4 5 6 7 8 9 lO ll 12 
x lo-4a2 
6 L-L 144 59 49 - - - - - - -
6 FA 144 93 63 38 29 23 17 14 12 98 
6 A(2) 316 llO 38 31 20 18 12 ll 178 70 
6 A(3) - 196 90 82 28 26 25 14 14 13 
9 Q,BP 192 71 36 23 18 14 11,87 70 58 
x lo-4cr2 
6 L-L 469 93 6o - - - - - - -
6 FA 469 144 lOO 58 38 30 22 17 15 12 
6 A(2) 284 196 85 48 26 22 16 13 lO 185 
6 A(3) 188 176 172 ll3 52 37 32 17 16 15 
9 Q,BP 588 139 64 36 23 18 14 11186 70 
x lo-3cr2 
6 L-L 231 30 16 - - - - - - -
6 FA 231 98 71 4o 29 23 17 14 12 94 
6 A(2) 955 31 17 J 62 54 38 35 24 21 15 
6 A(3) - 219 ls6 37 27 13 8 8 6 5 
9 Q,BP 235 52 22 12182 65 51 4o 32 26 
13 14 15 
x lo-5cr2 
- - -
85 74 63 
56 53 42 
86 82 79 
50 44 38 
x lo-5cr2 
- - -
98 86 73 
65 59 49 
lO lO 190 
58 50 43 
x lo-4cr2 
- - -
80 70 6o 
14 ll ll 
5 4 3 
22 19 16 
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4. Direct-by-First Order Residual Treatment Interaction 
A linear model having direct, residual and direct-by-residual treatment 
interaction is given by: 
(4.1) 
where ~Ptr is an interaction effect of t\h direct and rth one period residual 
effect and the other effects are as defined for (3.4). 
Four linearly independent contrasts among the ~Ptr terms in (4.1) which 
jointly define direct by residual interaction can be defined as: 
9 = ~PAA - ~PAB - ~PBA + ~PBB ' (4.2) AA,BB 
9AB BC = ~PAB - ~PAC - ~PBB + ~PBC ' (4.3) 
' 
9BA,CB = ~PBA - ~PBB - ~PeA + ~PCB ' (4.4) 
and 
6BB,CC = ~PBB - ~PBC - ~PCB + ~Pee . (4.5) 
Any other contrast or any other LIN set of contrasts can be obtained as 
linear combinations of these. In order to estimate such a set of four LIN con-
trasts under model (4.1), it is necessary that treatments precede themselves in 
the sequences. If a linear model has mth order residual effects, one will need 
to have treatments applied over m+l successive periods. The QBP design is the 
only three treatment crossover design among those considered in this chapter, 
for which (4.2) - (4.5) are estimable under (4.1). 
Since the treatments never precede themselves in the FA design, the 
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~Pii' i=l,···,v terms never appear so that no individual function in (4.2) 
(4.5) is estimable. An estimable fUnction which does not involve the ~p .. terms 
11 
in (4.1) is the difference between (4.3) and (4.4), i.e., 
(4.6) 
The L~L and A(k) designs are modified versions of FA where one or more of the 
rows of the basic FA design is repeated. While the four simple contrasts in (4.2) 
- (4.5) are not estimable, one can construct a set of four LIN estimable functions 
involving differences of (4.2) - (4.5). One such set of LIN functions is: 
9AA,BB - 9BB,CC ' 
e e AB,BC - BA,CB ' 
e + 2e AA,BB AB,BC ' 
and 
5. Cumulative Treatment-by-Period Interaction Effects 
Treatment-by-period interaction effects for linear models having both direct 
and residual treatment effects are parameterized in terms of cumulative treatment 
by period interactions (CTPI) effects. This parameterization arises from con-
sidering models having both direct and residual effects and their corresponding 
interactions with periods. 
Cumulative treatment effects (CT) are defined as the arithmetic sums of the 
direct and residual treatment effects. If contrasts among direct and residual 
effects are estimable, then so are the corresponding contrasts among CT with their 
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BLUEs being the sum of the corresponding BLUEs for direct and residual effects. 
Estimability of contrasts among direct and among residual effects ensures the 
estimability of the corresponding contrasts among CT. Such is not the case for 
CTPI. Designs which permit estimation of CTPI are characterized by the applica-
tion of the same treatment to individual s.u. 's fork successive periods. The 
number of successive applications that are required for estimability is a func-
tion of the number of residual effects present in the model. Consider a model 
with mth order residual effects. In order to estimate at least one contrast 
among CTPI within a minimum number of periods, the s.u. 's must receive m+2 suc-
cessive applications of the same treatment as it takes m+l periods for the cumula-
tive effects to manifest themselves on the individual e.u. 's and at least one 
more treatment application is needed in order that the CT appear in at least two 
periods, thus defining a within-s.u. contrast among the CTPI. The successive 
applications of treatments causes part of the sequence to define a CR design. By 
using factorial theory, contrasts among CTPI can be constructed as in CR designs. 
The model that is considered in this section is: 
(5.1) 
where arrhi defines the interaction between the hth cumulative treatment effect 
and the ith period effect and 
= l if h = t = r 
~tr 
= 0, otherwise 
The remaining effects in (5.1) are defined according to (3.4). Define a contrast 
among CTPI as: 
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9ij,i'j' = arrij- arrij' - arri'j + arri'j' (5.2) 
for i,i' = l,··· ,v, i fo i' and j,j' = l,···,p, j fo j' • Contrasts among the inter-
action effects in (4.1) can be defined in terms of LIN 9's in (5.2) or LIN sets 
of linear combinations of the 9's. 
The designs that provide estimators of contrasts among cumulative treatment-
by-period interaction (CTPI) effects are L-L for p = 5, A(3) for p ~ 6 and QBP 
for p ~ 2v. Note that for CAC-W and FA, ~tr = 0 for every i and j so that con-
trasts among CTPI are not estimable under (5.1). For A(2), the contrasts among 
CTPI are completely confounded with sequences. The L-L design for three treatments 
has CTPI effects appearing only in periods four and five. For this design estima-
tors of the 9's are: 
/', (-y4 - - -9A4,B5 = + y5l· + y43· - y53· l· 
- - - - )/2 + y44- - y 4 - y4 + y55· 
' 
5 • 5· 
A 
(-y42· - -9A4,C5 = + y52· + Y43· - y53· 
- - -
+ y56· )/2 + Y44. - y 4 - y46· 
' 5 • 
and 
~ ~ A4,C5 - A4,B5 
= (y4l· - y5l· - y42· + y52· 
+ y45· - y55· - y46· + y56· )/2 
The variance of each of these estimators is 2cr2 (1-p)/n where it is assumed that 
k = l,···,n for every j. For an A(3) design, the estimable contr~sts among CTPI 
are of the form: 
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e f'or .. 1 = A,B,C, i I= i1 ij,i 1j 1 l,l (5.3) 
j = 2,5,8, j 1 = j+l . 
Other estimable functions can be obtained by taking suitable linear combinations 
of' the contrasts defined by (5.2). The BLUEs of' the 9's will be defined by 
linear combinations of' those cell means where n - l. For example, 
''htr-
~ 2 (A 2 A 
with var(8A2,B3) = cr (1-p). In general, var 8 ... 1 • 1) = cr (l-p) where 8 ... 1 ., lJ,l J lJ,l J 
is defined by (5.2). The total number of LIN estimable contrasts will be 
(v-l)[v(k-1)-l]. Note that a total of (v-l)(kv-2) LIN contrasts would be estim-
able for a CR(v,v,kv) design. The remaining 2(v-l)2 CTPI contrasts which are not 
estimable for A(3) are completely confounded with contrasts among the sequence 
effects in (5.1). 
For QBP, contrasts among CTPI are estimable under (5.1) only when p > 2v+l. 
Consider the QBP design f'or v = 3. To form a design with p > 2v the additional 
periods can be obtained by repeating the basic design in such a way that periods 
l,··· ,2v are QBP as are period 2v+l,··· ,4v, etc. Certain contrasts among the CTPI 
will be estimable for the QBP design when v = 3 and p > 2v+l. For example, for 
p = 8, e. 2 .8 , i,j = A,B,C i /= j are estimable. When p = 9, additional estimable 
l 'J 
9 1 s are of the form ei3,j9 and for p = 10, ei4 ,jlO" For each additional period 
after the 7th, the estimable functions will be of the form e.h "k' i,j = A,B,C; 
l 'J 
h = k-6, k = 8,9,··· . For p > 2v+l there are (v-l)(p-2v+l) LIN estimable functions 
involving the CTPI effects in (5.1). The variance of' estimators of each estimable 
e ... 1"' is 2~(1-p). lJ,l J 
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The A(3) design not only minimizes the variances of estimators of contrasts 
among CT, but it also minimizes the variances of estimators of contrasts among 
CTPI. In general, the efficiency of an A(k) design for estimating contrasts 
among CT and CTPI will improve with increasing k, but the disadvantage of doing 
so is that the number of treatment periods may become prohibitively large. 
6. Some Four Treatment Crossover Designs 
Variance optimality of the L-L, FA, QBP and A(k) designs for four treat-
ments were assessed in terms of their ability of minimize the generalized var-
iance of a set of estimators of three linearly independent (LIN) contrasts among 
the direct, first-order residual and cumulative treatment effects by using (3.1), 
(3.2) and (3.3), respectively. However, to save space, only the results for 
direct effects are given (Table 5). Those for residual and cumulative effects 
are given in Kershner (1980). The L-L, FA and A(k) designs are compared when 
the number of sequences is 4, 8, 12 and 16. The number of treatment periods is 
varied from four to twenty. The QBP design is only defined for sixteen sequences 
while the FA, A(k) and L-L designs can be constructed for any multiple of four 
sequences. 
The FA design is constructed by using one or more designs from an orthogonal 
set of latin squares. As noted in Federer and Atkinson (1964), these designs are 
constructed for a varying number of periods and sequences by repeating orthogonal 
squares across the columns and down the rows of the design. The A(k) designs are 
obtained from the FA designs by repeating each treatment period k times. The 
L-L designs are obtained from an FA design having p = 4 by repeating the last 
period one or two times. Some additional designs having four sequences are con-
sidered here. These designs start with a balanced Williams (1949) design for 
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s = 4 and p = 4. This basic design is then repeated down the rows in order to 
define the appropriate number of treatment periods. These designs are denoted 
as L-L*, FA* and A(k)* in Table 6. Thus, for example, an L-L* design is a Wil-
liams (1949) design with the last period replicated one or two times while an 
L-L design uses one or more orthogonal Jatin squares rather than a Williams design. 
Table 6 gives the generalized variance for direct effects as defined by (3.1). 
The single latin square design (L-L and FA) and the four sequence PBIB crossovers 
[A(2) and A(3)] do not perform well when compared to crossovers utilizing the 
Williams (1949) design; i.e., L-L*, FA*,A(2)* and A(3)*. Among the four sequence 
designs, the L-L* design is optimal for direct effects when p = 5 or 6. When 
p = 4, FA~• and L-L* are variance optimal. It is interesting to note that FA* and 
L-L are equally efficient for direct effects when p = 5. 
Among those designs utilizing the basic construction given in Federer and 
Atkinson (1964), the L-L design is variance optimal when p = 5 or 6. When s = 16, 
QBP is optimal for direct effects for p ~ 6. As the number of treatment periods 
is varied from four to twenty, the FA* and A(2)* designs offer interesting com-
parisons. Note that A(2)* is more efficient than FA* when p = 7, 9, 11, 13, 15, 
17, 19 and 20. When p = 18, these designs are equally efficient. The FA and 
A(2) designs do not have the same pattern. The A(2) design is more efficient than 
FA when p = 7 and 15. When p = 9, 17 and 19 these designs are equally efficient. 
For residual effects, the four sequence designs based on Williams (1949) 
construction are uniformly more efficient for estimating contrasts among first-
order residual effects than designs which use an unbalanced single latin square. 
Among the designs using the Federer and Atkinson (1964) construction, the FA and 
L-L designs are variance optimal for residual effects at p = 4 and s = 8, 12 or 
16. When s = 4 and p = 4, A(2) is variance optimal. When p = 5 or 6, L-L is 
s Design 
4 L-L* 
FA* 
A(2)~~ 
A(3)* 
1-L 
FA 
A(2) 
A(3) 
8 L-L 
FA 
A(2) 
A(3) 
12 L-L 
FA 
A(2) 
A(3) 
16 L-L 
FA 
A(2) 
A(3) 
QBP 
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Table 6 
Values of the Generalized Variance for a LIN Set of 
Three Estimable Contrasts Among Direct Effects 
Number of Treatment Periods 
4 5 6 7 8 9 10 ll 12 13 14 15 16 
x lo-3cr2 X 10-4~ 
83 36 28 - - - - - - - - - -
83 58 33 24 ll 95 66 55 36 31 24 21 16 
374 105 52 16 13 82 75 45 4o 28 25 17 15 
844 250 216 51 36 32 ll 10 94 54 52 50 29 
416 58 4o - - - - - - - - - -
416 217 39 27 ll 95 67 45 33 26 21 17 14 
76 73 47 21 17 95 85 46 41 28 25 17 15 
-
62 58 46 34 32 14 13 12160 58 56 29 
X lo-4cr2 X l0-5cr2 
135 50 38 - - - - - - - - - -
135 72 39 24 14 10 76 55 4o 32 26 21 17 
399 74 53 21 18 10 94 55 50 33 30 21 19 
934 289 248 46 39 36 14 13 12167 64- 63 35 
x lo-4cr2 x lo-5~ 
31 13 10 - - - - - - - - - -
31 18 ll 65 4o 29 22 16 12 10 8 6 5 
100 20 15 59 50 29 26 16 15 10 9 6 6 
233 73 64- 13 ll 10 4o 37 35 19 18 18 10 
x lo-5cr2 x lo-6cr2 
138 58 44 - - - - - - - - - -
138 79 47 28 17 12 92 68 50 4o 33 26 21 
445 87 64 25 21 12 ll 68 62 41 37 26 24 
lo40 324 280 55 47 44 17 16 15181 78 75 44 
211 71 35 19 12,89 66 50 38 30 24 19 15 
17 18 19 20 
- - - -
14 ll 10 8 
12 ll 9 8 
27 26 18 17 
-
-
- -
12 10 9 7 
12 ll 9 8 
28 27 . 18 17 
- - - -
14 12 10 9 
14 14 10 10 
34 33 21 20 
- - - -
4 4 3 3 
4 4 3 3 
10 10 6 6 
- - - -
18 15 13 ll 
18 17 13 12 
42 41 26 25 
13 ll 9 8 
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optimal for residual effects. Among the sixteen sequence designs, QBP is variance 
optimal for residual effects when p ~ 7. The A(2)* design is more efficient for 
residual effects that FA* when p = 9, 11, 13, or 15 or when p ~ 17. The A(2) 
design is more efficient than FA for p = 4 or 7. When p = 9, 17, or 19, A(2) 
and FA are equally efficient. Neither A(3) nor A(3)* are efficient designs for 
direct or residual effects, but these designs are variance opt~mal for estimating 
contrasts among cumulative treatment effects when the number of periods is suf-
ficiently large. 
The values of the generalized variance of contrasts among cumulative treat-
ment effects are given by Kershner (1980). The A(3)* design.is variance optimal 
for cumulative effects when p ~ 9 while for s ~ 8, A(3) is optimal when p ~ 9. 
When s = 4 and p = 4 or 5, L-L* is optimal for cumulative effects, and when p = 6, 
7 or 8, A(2)# is optimal. When s ~ 8 and p = 4, 6, 7 or 8, A(2) is a variance 
optimal design for cumulative effects, and when p = 5, L~L* is optimal. 
7. Discussion 
As may be noted above, variance optimality of the type discussed here is not 
invariant with respect to type of design, number of sequences, number of periods, 
and number of treatments. Some designs have fairly good properties throughout 
the range of these variables. This means that an experimenter using a squential 
procedure for number of periods will have a dilemna in that the best design may 
depend upon the number of periods. In this case, it will be necessary to use the 
design which has relatively low variances for all periods. 
The problem of measures of efficiency of designs taking into account some 
weighted function of direct, one-period residual, two-period residual, etc. ef-
fects still needs to be considered. We used the v-1 linearly independent contrasts 
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among v treatments for direct effects and for residual effects. Then, we used 
the same measure among direct plus residual equal cumulative effects. This gives 
equal weights to direct and residual effects which may not be appropriate in some 
situations. 
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